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Abstract
Background: Chronic hepatitis B virus (HBV) infection is the leading cause of liver disease and liver cancer and a
major source of health-related discrimination in China. To better target HBV detection and prevention programs, it
is necessary to assess existing HBV knowledge, educational resources, reporting, and preventive practices,
particularly among those health professionals who would be responsible for implementing such programs.
Methods: At the China National Conference on the Prevention and Control of Viral Hepatitis on April 26-29, 2004,
the Asian Liver Center at Stanford University partnered with the China Foundation for Hepatitis Prevention and
Control to distribute a voluntary written questionnaire to Chinese healthcare and public health professionals from
regional and provincial Chinese Centers for Disease Control and Prevention, health departments, and medical
centers. Correct responses to survey questions were summed into a total knowledge score, and multivariate linear
regression was used to compare differences in the score by participant characteristics.
Results: Although the median score was 81% correct, knowledge about HBV was inadequate, even among such
highly trained health professionals. Of the 250 participants who completed the survey, 34% did not know that
chronic HBV infection is often asymptomatic and 29% did not know that chronic HBV infection confers a high risk
of cirrhosis, liver cancer, and premature death. Furthermore, 34% failed to recognize all the modes of HBV
transmission and 30% did not know the importance of the hepatitis B vaccine in preventing liver disease.
Respondents who reported poorer preventive practices, such as not having personally been tested for HBV and
not routinely disposing of used medical needles, scored significantly lower in HBV knowledge than those who
reported sound preventive practices. Of note, 38% of respondents reported positive HBsAg results to patients’
employers and 25% reported positive results to patients’ schools, thereby subjecting those with positive results to
potential discriminatory practices.
Conclusions: These results indicate that there is a need for development of effective educational programs to
improve HBV knowledge among health professionals and the general public to avoid missed vaccination
opportunities, reduce misconceptions, and eliminate discrimination based on chronic hepatitis B in China.
Background
The People’s Republic of China carries the greatest bur-
den of chronic hepatitis B virus (HBV) infection in the
world, with a greater than 8% hepatitis B surface antigen
(HBsAg) seroprevalence in a population of 1.3 billion
people [1,2]. Individuals chronically infected with HBV
have a one in four chance of dying from primary liver
cancer or cirrhosis if not medically managed [3], and an
estimated 60-80 percent of liver cancer cases in the Chi-
nese population are caused by chronic HBV infection
[4,5]. In comparison with HIV, which affects 700,000
Chinese [6], HBV has chronically infected an estimated
100 million Chinese, making it the most prevalent life-
threatening infection in China [6]. Each year HBV kills
260,000 to 280,000 people in China [7]–more than
tuberculosis (201,000) [8], HIV (39,000) [9], and malaria
(<50) [10] combined.
As a blood-borne pathogen, HBV is primarily trans-
mitted via perinatal/mother-to-child exposure, sexual
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and occupational (health-care-related) exposure [11]. In
China, where HBV infection is endemic, vertical trans-
mission at childbirth is the predominant route of
chronic infection [12]. Vertical transmission can be pre-
vented through the administration of the hepatitis B
vaccine and hepatitis B immune globulin at birth [13].
Among those who are chronically infected, routine
screening for liver cancer can lead to early detection
and a reduced risk of death [14].
Despite the presence of effective HBV and liver cancer
screening measures and the implementation of a free
hepatitis B vaccine program for all neonates by the Chi-
nese government in 2002 [15], HBV continues to be a
leading cause of mortality in China, with liver cancer
ranking as the second most common cancer site among
men and the fifth among women [16]. The persistence
of high HBV-related mortality rates could be attributed
in part to a lack of health provider knowledge, which
can be a major obstacle to implementation of preventive
programs. Yet, to our knowledge, the only study on
health provider knowledge of HBV in China was a 1993
study by Clayton et al., who found poor HBV-related
knowledge and widespread unsafe needle-use practices
among village doctors in rural Minhou county in Fujian
province [17]. With no wider studies on this topic, we
set out to assess HBV-related knowledge among health
professionals, including Chinese healthcare and public
health professionals from regional and provincial Chi-
nese CDC, health departments, and medical centers–i.e.,
those who should be the best-educated in viral hepatitis
prevention. This survey enabled us to identify areas of
HBV-related knowledge deficits, as well as associations
of HBV preventive actions or demographics with levels
of HBV knowledge. Our goal was to highlight the suc-
cesses in HBV prevention while also determining the
nature of obstacles in effective HBV prevention, so as to
inform the design of future initiatives aimed at reducing
the burden of HBV in China.
Methods
Study population
Voluntary written questionnaires were administered as
part of the registration process at the China National
Conference on the Prevention and Control of Viral
Hepatitis held on April 26-29, 2004, in Hangzhou,
China. The meeting was organized by the China Foun-
dation for Hepatitis Prevention and Control, a national
non-profit organization affiliated with the China CDC.
Participants comprised public health and healthcare pro-
fessionals from the provincial and regional CDC, health
departments and medical centers. Conference attendees
were asked to complete the questionnaire on-site at the
conference at the time of registration, prior to being
influenced by the conference proceedings. Signed con-
sent to participate in the survey was obtained by the
China Foundation for Hepatitis Prevention and Control.
Among approximately 600 conference attendees, 250
completed the questionnaire; information was not
obtained on attendees (including vendors) who did not
complete the questionnaire.
Questionnaire
The questionnaire was developed in-language (simplified
Chinese) by the Asian Liver Center at Stanford Univer-
sity, based on its past experience with administering
hepatitis B knowledge surveys in other populations, and
with input from the China Foundation for Hepatitis Pre-
vention and Control. The questionnaire consisted of
four sections: i) HBV knowledge, ii) HBV prevention
and reporting practices, iii) HBV educational resources,
and iv) demographics and personal HBV-related health
history. The knowledge section tested basic HBV and
liver cancer knowledge concerning disease transmission,
age-group risk, testing, incidence, whether treatment is
curative, symptoms, outcomes, causes of liver cancer,
prevention of perinatal transmission, modes of transmis-
sion, preventive measures, vaccination, and management
of infected individuals. The section on HBV practices
surveyed local test reporting, local restrictions on
infected individuals, local vaccination practices, and nee-
dle disposal policies. The third section surveyed local
HBV education. The fourth section surveyed participant
demographics and personal HBV preventive actions.
Statistical methods
An overall knowledge score was determined based on
the sum of correct answers to the 16 knowledge-based
questions. A correct response to each question received
one point; incorrect and missing responses received no
points. Knowledge questions that had multiple correct
answers were awarded one point only if respondents
selected all correct answer choices. Questions on local
HBV practices, HBV education, and participant HBV
preventive actions were categorized as “yes” if the parti-
cipant reported performing the action and “no” if he or
she did not. Missing responses were excluded because
they were considered to be uninformative.
Univariate associations of demographic characteristics,
participant HBV preventive practices, local HBV prac-
tices, and local HBV educational resources with knowl-
edge score were assessed using linear regression to
estimate the difference of total knowledge score (in con-
tinuous points with a corresponding 95% confidence
interval [CI]) between groups. We grouped the 35 pro-
vinces and other administrative areas in China into 3
regions (East, Central, West) based on the regions
defined in a 2004 study of hepatitis B vaccine coverage
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that were marginally (p < 0.10) associated with knowl-
edge score were included in multivariate regression
models for knowledge score. Multivariate models were
adjusted for rural/urban status of residence, education
level, occupation, whether or not the respondent had
been tested for HBV, local test result notification prac-
tices, and local availability of free vaccines. Data were
analyzed using SAS version 9.1.3 (SAS Institute, Cary,
NC).
Results
The demographic and some HBV-related characteristics
of the study population are shown in Table 1. Most par-
ticipants were male, urban, university-educated health-
care or public health professionals.
Hepatitis B knowledge level
Out of a total knowledge score of 16, the median knowl-
edge score was 13 (81%) correct (range = 4 to 16); 13
individuals (5%) responded correctly to all of the knowl-
edge questions. Although five questions were correctly
answered by more than 90% of participants, there was
deficient HBV knowledge in several areas (Table 2). For
example, 34% of respondents did not know that chronic
HBV infection does not usually have symptoms and 29%
did not know that chronic HBV infection can lead to
liver cirrhosis, liver cancer, and premature death.
Another 19% of respondents did not know that both
HBV and hepatitis C virus (HCV) infection can lead to
chronic (lifelong) infection. Thirty-four percent were
unaware that contaminated blood, contaminated nee-
dles, unprotected sex with an infected person, and birth
to an infected mother are all modes of HBV transmis-
sion. Furthermore, 30% of individuals did not know that
giving the hepatitis B vaccine and avoiding the reuse of
needles are two of the best ways to prevent HBV trans-
mission. Only 31% of health workers knew that alpha-
fetoprotein (AFP), alanine aminotransferase (ALT), and
ultrasound tests should be performed to test liver func-
tion and screen for liver cancer in someone chronically
infected with HBV.
Hepatitis B prevention, reporting practices, and public
educational resources
Of the individuals surveyed, 18% said that they do not
report a positive HBsAg screening test result directly to
the patient (Table 2). Conversely, 38% reported a posi-
tive HBsAg test result to the patient’s employer and
25% reported a positive result to the patient’s school–
practices that exacerbate employer- and school-based
discrimination against HBsAg-positive individuals in
China [19,20]. Likewise, 28% of health workers reported
that an infected individual in their city was prohibited
from attending school and 27% said that infected indivi-
duals are prohibited from entering the healthcare indus-
try. With regard to local vaccination policies, 90% of
health workers reported that their city/village, at the
minimum, provides free vaccines for newborns, and most
do so for healthcare workers as well. However, 15% of
health professionals did not know how their hospital or
clinic handled used needles and 20% did not have health
information about HBV available at their workplace.
Hepatitis B preventive actions
Nearly all participants reported that they and their chil-
dren had received the hepatitis B vaccine series and that
they themselves had been tested for HBV infection (Table
1). Nearly one-third had a family history of chronic hepati-
tis B and 8.5% had a family history of liver cancer. Thirty-
seven percent had heard of the Jade Ribbon Campaign, an
international initiative launched by the Asian Liver Center
at Stanford University in 2001 to increase hepatitis B and
liver cancer awareness and prevention.
Associations with hepatitis B knowledge level
After adjusting for other influences on HBV-related
knowledge, individuals from rural provinces scored, on
average, 1.0 point lower (95% CI: -1.6, -0.3 points) in
HBV-related knowledge questions compared with those
from urban provinces (Table 3). In addition, individuals
who had completed only high school or vocational school
scored 1.2 and 1.3 points lower, respectively, than indivi-
duals who had completed college or university. Of the
occupations surveyed, nurse/midwives scored 2.4 points
lower (95% CI: -4.3, -0.5) than physicians on HBV-related
knowledge questions, while elementary school staff
scored 3.9 points lower (95% CI: -7.4, -0.4). Health pro-
fessionals who reported having personally been screened
for HBV scored 1.2 points higher (95% CI: 0.1, 2.3) than
health workers who did not report having been tested.
Having been vaccinated or having had one’s children vac-
cinated against HBV was not significantly associated with
differences in knowledge score.
In terms of local HBV-related practices, health profes-
sionals who reported positive HBsAg test results only to
schools and/or employers scored significantly lower (-1.5
points, 95% CI: -2.1, -0.9) than health workers who
reported results only to the patient (with or without
reporting to the health department). In addition, indivi-
duals who reported that their local hospitals disinfected
and reused needles scored significantly poorer (-2.0 points,
95% CI: -4.1, 0.0) than those whose hospitals destroyed
needles on-site after a single use. However, health workers
who reported employment, schooling, and/or community
restrictions on persons with chronic HBV infection in
their city/village did not score significantly lower than
health workers who reported no such restrictions.
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Our results show that even in our sample of highly edu-
cated healthcare providers and public health profes-
sionals, HBV- and liver-cancer-related knowledge,
practices, and education were deficient, especially
among health workers from rural provinces of China,
those with lower general education, and nurses, mid-
wives, and elementary school staff. HBV-related knowl-
edge scores were higher among participants from areas
with patient-directed HBV test notification procedures
and strict needle disposal practices, suggesting that HBV
knowledge and sound health policy are intertwined.
Table 1 Distribution of demographic characteristics and hepatitis B preventive practices among health professionals in
China
Characteristic N (%) Characteristic N (%)
Sex Education level
Male 146 60.1 Elementary 1 0.4
Female 97 39.9 Middle school 1 0.4
Unknown 6 High school 18 7.4
Province of residence Vocational 29 11.8
Heilongjiang 4 1.7 University/college 181 73.9
Jilin 13 5.6 Graduate/professional degree 15 6.1
Liaoning 3 1.3 Unknown 4
Beijing 16 6.9 Occupation
Inner Mongolia 4 1.7 Physician 83 34.6
Gansu 26 11.2 Nurse or midwife 5 2.1
Xinjiang 2 0.9 Elementary school teacher/admin 1 0.4
Qinghai 10 4.3 Social worker 13 5.4
Ningxia 2 0.9 Government public health worker 42 17.5
Shanxi 7 3.0 Local public health worker 83 34.6
Hebei 18 7.8 Hospital administrator 13 5.4
Shandong 9 3.9 Unknown 9
Jiangsu 14 6.0 Family history of chronic hepatitis B
Henan 19 8.2 Yes 72 30.8
Shaanxi 20 8.6 No 162 69.2
Sichuan 5 2.2 Unknown 15
Tibet 1 0.4 Family history of liver cancer
Chongqing 2 0.9 Yes 19 8.5
Hubei 4 1.7 No 204 91.5
Anhui 3 1.3 Unknown 26
Shanghai 3 1.3 Ever been tested for HBV
Zhejiang 18 7.8 Yes 225 94.9
Jiangxi 4 1.7 No 12 5.1
Fujian 2 0.9 Unknown 12
Hunan 2 0.9 Vaccinated against HBV
Yunnan 2 0.9 Yes 195 81.6
Guangxi 5 2.2 No 44 18.4
Guangdong 14 6.0 Unknown 10
Unknown 17 Children vaccinated against HBV
Rural/urban status of residence Yes 226 95.8
Rural 39 16.0 No 10 4.2
Urban 205 84.0 Unknown 13
Unknown 5 Ever heard of the Jade Ribbon Campaign
Population of town/city of residence Yes 88 37.3
<10,000 17 7.0 No 148 62.7
10,000-50,000 75 30.9 Unknown 13
500,000-1 million 42 17.3
>1 million 109 44.9
Unknown 6
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knowledge and local hepatitis B practices among health
professionals in China
Survey question N (%)
HBV knowledge
Which of the following viruses is transmitted like HIV?
Correct 228 91.6
Incorrect/missing 21 8.4
Which of the following age groups, if infected, is at highest risk of
developing chronic HBV infection?
Correct 223 89.6
Incorrect/missing 26 10.4
Which of the following blood tests measures protection against HBV?
Correct 209 83.9
Incorrect/missing 40 16.1
How many people in China have chronic HBV infection?
Correct 234 94.0
Incorrect/missing 15 6.0
Which of the following is a curative treatment for HBV?
Correct 216 86.8
Incorrect/missing 33 13.2
Does chronic hepatitis B usually cause symptoms?
Correct 165 66.3
Incorrect/missing 84 33.7
What are the potential complications of chronic HBV infection?
Correct 177 71.1
Incorrect/missing 72 28.9
What is the most common cause of liver cancer in
China?
Correct 235 94.4
Incorrect/missing 14 5.6
If a pregnant woman is an HBV carrier, which of the following is the best
way to prevent perinatal transmission?
Correct 214 85.9
Incorrect/missing 35 14.1
Which of the following viruses is transmitted by contaminated water?
Correct 240 96.4
Incorrect/missing 9 3.6
Which of the following forms of viral hepatitis is vaccine-
preventable?
Correct 239 96.0
Incorrect/missing 10 4.0
Which of the following forms of viral hepatitis can lead to chronic
hepatitis?
Correct 201 80.7
Incorrect/missing 48 19.3
What are the modes of HBV transmission?
Correct 164 65.9
Incorrect/missing 85 34.1
What are the best ways of preventing transmission of HBV?
Correct 175 70.3
Incorrect/missing 74 29.7
Who should be vaccinated if they are not protected against HBV?
Correct 221 88.8
Incorrect/missing 28 11.2
Table 2: Distribution of hepatitis B and liver cancer
knowledge and local hepatitis B practices among health
professionals in China (Continued)
What are the tests used to monitor patients with chronic HBV infection?
Correct 77 30.9
Incorrect/missing 172 69.1
HBV health practices
If someone tests positive for HBV, do you report the results to the patient?
Yes 202 82.1
No 44 17.9
If someone tests positive for HBV, do you report the results to the patient’s
employer?
Yes 93 37.8
No 153 62.2
If someone tests positive for HBV, do you report the results to the patient’s
school?
Yes 61 24.8
No 185 75.2
If someone tests positive for HBV, do you report the results to the health
department?
Yes 105 42.7
No 141 57.3
Does your city/village prohibit HBV-infected individuals from working for
the government?
Yes 25 13.0
No 167 87.0
Does your city/village prohibit HBV-infected individuals from attending
schools?
Yes 53 27.6
No 139 72.4
Does your city/village require HBV-infected individuals to have separate
eating utensils/plates?
Yes 35 18.2
No 157 81.8
Does your city/village prohibit HBV-infected individuals from working in
healthcare?
Yes 52 27.1
No 140 72.9
What population groups receive free hepatitis B vaccines in your city/
village?
Vaccines are free for newborns (± other groups) 222 89.5
Vaccines are free for health workers only 5 2.0
Vaccines are only for purchase 19 7.7
Vaccines are not available 2 0.8
What do clinics/hospitals do with used needles in your city/village?
Single use and destroy on site 186 75.3
Single use but collected by supplier for disposal 19 7.7
Disinfect and reuse 6 2.4
Don’t know 36 14.6
Do you display or have available HBV educational material in your
workplace?
Yes, we have posters 69 27.7
Yes, printed information is available by request 62 24.9
Both 69 27.7
No 49 19.7
HBV: hepatitis B virus
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Characteristic Unadjusted difference 95% Confidence Interval p-value
Sex
Male 0.0 reference
Female 0.2 (-0.4, 0.7) 0.57
Region of residence
Eastern 0.0 reference
Central 0.3 (-0.3, 1.0) 0.29
Western -0.8 (-1.5, -0.2) 0.01
Rural/urban status of residence
Rural -1.8 (-2.4, -1.1) <0.001
Urban 0.0 reference
Population of town/city of residence
<10,000 -1.5 (-2.5, -0.5) 0.005
10,000-500,000 -0.5 (-1.0, 0.1) 0.12
500,000-1 million -0.2 (-0.9, 0.5) 0.57
>1 million 0.0 reference
Education level
Elementary 0.7 (-3.2, 4.7) 0.71
Middle school -0.3 (-4.2, 3.7) 0.90
High school -1.8 (-2.7, -0.8) <0.001
Vocational -1.3 (-2.1, -0.5) 0.002
University/college 0.0 reference
Graduate/professional degree -0.3 (-1.4, 0.7) 0.56
Occupation
Physician 0.0 reference
Nurse or midwife -5.0 (-6.8, -3.2) <0.001
Elementary school teacher/admin -3.2 (-7.2, 0.7) 0.11
Social worker -0.3 (-1.5, 0.9) 0.62
Government public health worker -0.2 (-1.0, 0.5) 0.57
Local public health worker -0.2 (-0.8, 0.4) 0.51
Hospital administrator -0.4 (-1.6, 0.7) 0.45
Family history of chronic hepatitis B
Yes 0.0 (-0.6, 0.6) 0.92
No 0.0 reference
Family history of liver cancer
Yes -0.6 (-1.5, 0.4) 0.25
No 0.0 reference
Ever been tested for HBV
Yes 1.9 (-0.7, 3.0) 0.002
No 0.0 reference
Vaccinated against HBV
Yes 0.5 (-0.2, 1.1) 0.19
No 0.0 reference
Children vaccinated against HBV
Yes 1.1 (-0.2, 2.5) 0.09
No 0.0 reference
Ever heard of the Jade Ribbon Campaign
Yes 0.0 (-0.6, 0.5) 0.92
No 0.0 reference
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Hepatitis B health practices
If someone tests positive for HBV, do you report the results to the ...?
Only to the patient (± health department) 0.0 reference
To the patient and the patient’s school or employer -0.5 (-1.1, 0.1) 0.08
Only to the patient’s school or employer -1.9 (-2.6, -1.2) <0.001
Does your city/village restrict HBV-infected individuals from working for the government?
Yes 0.7 (-0.2, 1.7) 0.11
No 0.0 reference
Does your city/village restrict HBV-infected individuals from attending schools?
Yes 0.5 (-0.2, 1.2) 0.19
No 0.0 reference
Does your city/village require HBV-infected individuals to have separate eating utensils/plates?
Yes 0.0 (-0.8, 0.8) 0.97
No 0.0 reference
Does your city/village restrict HBV-infected individuals from working in healthcare?
Yes 0.2 (-0.5, 0.9) 0.56
No 0.0 reference
What population groups receive free hepatitis B vaccines in your city/village?
Vaccines are free for newborns (± other groups) 0.0 reference
Vaccines are free for health workers only -1.6 (-3.4, 0.3) 0.10
Vaccines are only for purchase 0.3 (-0.7, 1.2) 0.61
Vaccines are not available -3.5 (-6.4, -0.6) 0.02
What do hospitals do with used needles in your city/village?
Single use and destroy on site 0.0 reference
Single use but collected by supplier for disposal 0.9 (-0.1, 1.9) 0.07
Disinfect and reuse -3.2 (-4.8, -1.5) <0.001
Don’t know 0.5 (-0.2, 1.2) 0.26
What forms of HBV educational material do you utilize in your workplace?
Posters 0.3 (-0.5, 1.1) 0.42
Printed information 0.4 (-0.3, 1.2) 0.28
Posters and printed information 0.5 (-0.3, 1.3) 0.22
None 0.0 reference
Adjusted difference* 95% Confidence Interval p-value
0.0 reference
-0.1 (-0.5, 0.4) 0.84
0.0 reference
0.0 (-0.6, 0.6) 0.99
-0.3 (-0.9, 0.3) 0.28
-1.0 (-1.6, -0.3) 0.004
0.0 reference
-0.5 (-1.5, 0.5) 0.32
-0.1 (-0.7, 0.4) 0.67
-0.1 (-0.7, 0.5) 0.79
0.0 reference
0.3 (-3.1, 3.8) 0.85
-0.6 (-4.0, 2.9) 0.75
-1.2 (-2.1, -0.3) 0.008
-1.3 (-2.0, -0.5) <0.001
0.0 reference
0.1 (-0.9, 1.1) 0.84
0.0 reference
-2.4 (-4.3, -0.5) 0.01
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improved, targeted education and training of health pro-
fessionals in regions with low HBV-related knowledge in
order to increase preventive practices and decrease rates
of transmission and morbidity and mortality due to
chronic HBV infection.
Recent progress in China
Several noteworthy advances have been made in HBV
prevention and knowledge in China during the past dec-
ade. In 1992, the Chinese government recommended
routine hepatitis B vaccination of infants, but high vac-
cine prices and user fees barred all but the wealthiest
persons from being vaccinated [15]. Therefore, in 2002,
the Chinese Ministry of Health partnered with the
GAVI Alliance (formerly the Global Alliance for Vac-
cines and Immunisation) to distribute hepatitis B vac-
cines to economically disadvantaged provinces and
counties in western and central China. Furthermore, in
2005, all charges and user fees for the hepatitis B vac-
cine were abolished, making the vaccine free to all chil-
dren in China. As a result of these programs, timely
coverage with the birth dose of hepatitis B vaccine
increased from 29.1% among children born in 1997 to
75.8% among children born in 2003; and completion of
the hepatitis B vaccine series rose from 70.7% among
children born in 1997 to 89.8% among those born in
2003. Coverage rates were even higher in the provinces
and counties targeted by the China-GAVI project [15].
Additional gains in HBV-related knowledge and preven-
tion among healthcare providers and public health pro-
fessionals could spur further acceleration in the pace of
HBV prevention and control throughout China, bringing
vaccination rates ever closer to 100%–particularly in the
underaddressed population of children and adolescents
born before 2003. In this latter group, successful pilot
catch-up vaccination programs [21-23], as well as strong
evidence that such programs would be cost-saving in
China [24], may provide the impetus needed to imple-
ment a nationwide universal catch-up vaccination pro-
gram for children and adolescents.
HBV knowledge
Perhaps due in part to the recent progress in HBV pre-
vention in China, most HBV knowledge questions on
our survey were correctly answered by more than half
of the participants, and the median overall score was
81% correct. Nevertheless, we found that critical gaps in
HBV knowledge are still present among trained health
workers in China. In particular, one-third of health
Table 3: Differences in hepatitis B knowledge scores among health professionals in China (Continued)
-3.9 (-7.4, -0.4) 0.03
0.0 (-1.1, 1.1) 0.99
0.3 (-0.4, 1.0) 0.42
-0.1 (-0.7, 0.5) 0.77
-0.2 (-1.3, 0.9) 0.73
0.0 (-0.5, 0.5) 0.93
0.0 reference
0.0 (-0.9, 0.9) 0.96
0.0 reference
1.2 (0.1, 2.3) 0.03
0.0 reference
0.5 (-0.2, 1.1) 0.15
0.0 reference
0.3 (-0.9, 1.6) 0.62
0.0 reference
0.0 (-0.4, 0.5) 0.84
0.0 reference
0.0 reference
-0.2 (-0.8, 0.3) 0.37
-1.5 (-2.1, -0.9) <0.001
0.2 (-0.6, 1.1) 0.59
0.0 reference
0.5 (-0.1, 1.2) 0.09
0.0 reference
*Adjusted for urban/rural status of residence, education level, occupation, HBV testing practices, HBV test notification practices, and availability of free vaccines
HBV: hepatitis B virus
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tomatic nature of chronic HBV infection, as well as the
endpoints of the disease, such as end-stage liver cirrho-
sis, liver cancer and premature death. Health workers
lacking such knowledge may overlook the importance of
screening asymptomatic children and adults, and vacci-
nating those who are susceptible. These observations are
consistent with our findingst h a th e a l t hw o r k e r sw h o
scored significantly higher on HBV knowledge-based
questions had also been screened and vaccinated for
HBV themselves.
Some health workers also fell short when it came to
knowledge about the basics of preventing the further
spread of the disease. One-third of health workers sur-
veyed were not sufficiently informed about all the
modes of transmission and the best ways to prevent
transmission, including vaccination and safe needle dis-
posal practices. Such lack of knowledge among health
workers could translate into similarly deficient knowl-
edge in the general population, thereby contributing to
insufficient preventive practices that enable the persis-
tence of high rates of HBV infection.
Based on our findings, these HBV knowledge deficits
were most substantial in rural regions of China. This
disparity may be partially attributable to the reported
difficulties in HBV training, vaccine transportation, vac-
cine storage, and vaccine costs in rural areas, where
21.5 million live below the official “absolute poverty”
line [17,25]. Indeed, a quarter of surveyed individuals
reported that there are no free hepatitis B vaccines
available in their city/village. Yet, it should be noted
that vaccine availability was not necessarily associated
with better HBV knowledge. For instance, individuals
from cities/villages that provided free vaccines to health
workers scored marginally lower on HBV knowledge-
based questions than those from cities/villages with only
purchasable vaccines. The reason for this paradox is
unclear and may be attributable to a lack of accompa-
nying provider education even when the vaccine itself is
available.
Health worker knowledge concerning the importance
of newborn vaccination was high. In 2002, infant hepati-
tis B vaccination was added to China’sN a t i o n a lI m m u -
nization Program, and the China-GAVI Project was
launched [15]. Consistent with these government-led
initiatives, our results show that the great majority of
health workers knew that newborns have the greatest
risk of becoming chronic HBV carriers, and that a
timely HBV birth dose given to newborns is the best
way to prevent transmission.
Our results also showed that nurses, midwives, and
elementary school staff had significantly lower HBV
knowledge scores than physicians, albeit based on a
small sample size. This result suggests the need to target
HBV education to nurses and midwives, some of whom
are the only health workers present at the time of new-
born delivery in rural regions, where low-income
families tend to give birth at home [15]; and to provide
better HBV information to elementary school teachers
and administrators, who can play a critical role in pro-
moting catch-up hepatitis B vaccination among vulner-
able schoolchildren who were not vaccinated at birth.
Additional obstacles to prevention
While improving provider and health worker knowledge
regarding HBV prevention is a necessary first step
toward HBV prevention, other additional obstacles often
hinder translation of knowledge into effective preventive
practices. In 1993 Clayton et al. performed a study using
a different self-administered questionnaire to evaluate
HBV knowledge and preventive practices among 260 vil-
lage doctors in the mostly rural Minhou county of the
Fujian Province [17]. They found that provider knowl-
edge often did not translate into preventive practices
with their patients. According to Clayton et al., 90%
local village doctors in Minhou county correctly identi-
fied the modes of HBV transmission. However, when
asked to give medical advice to imaginary patients, only
8.5% of the survey respondents advised vaccination and
only nine (3.5%) cautioned an HBsAg-positive patient
against giving blood. The authors of the study suggested
that HBV information may have been memorized, but
not enough training was given on how to put that infor-
mation into practice. Their findings contrast with those
from a 2007 study done in the San Francisco Bay Area
of California, where greater provider knowledge about
the risk factors/guidelines of HBV-associated primary
liver cancer in Asian Americans was correlated with
greater HBV screening efforts [26]. This country-to-
country difference suggests that gaps in implementation
of preventive practices in China cannot be accounted
for by lack of knowledge alone.
One explanation could be the stigma of chronic hepa-
titis B–a widespread basis for employment, school, and
social discrimination in China, but not in the United
States. A quarter of all health workers we surveyed sta-
ted that they report a positive test result to the patient’s
school, and an even greater proportion report the results
to the patient’s employer. These reporting policies sug-
gest that an underlying prejudice against chronically
infected individuals in China may deter at-risk indivi-
duals from getting screened (even if screening is avail-
able) and subsequently receiving the vaccine or being
monitored for liver cancer. In an effort to curtail HBV-
related discrimination, the Chinese Ministry of Health
and Ministry of Human Resources and Social Security
co-issued a notice in 2007 stating that an employer shall
not refuse to employ or dismiss an HBV carrier because
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banned from the job by laws, regulations, or Ministry of
Health rules [27]. In December 2009, the Ministry of
Health further announced that it would soon prohibit
the long-standing practice of mandatory HBV testing
during physical exams given for employment or school
enrollment, signaling further progress in fighting discri-
mination [28]. However, methods for supervising and
enforcing this new policy are unclear. Furthermore,
poor HBV-related knowledge in the general population–
and, most likely, among health professionals–still perpe-
tuates social discrimination against chronically infected
individuals in China [19,20].
Study limitations
Our research should be viewed with the following lim-
itations in mind. Firstly, all collected data were self-
reported and therefore not verifiable. In particular,
there was some inconsistency in the collected data (i.e.,
participants provided multiple answers to questions
that asked for only one answer), indicating that some
of the reported information was unreliable. Secondly,
because our study was cross-sectional in nature, we
cannot attribute causation to individual factors. (i.e.,
we could not show that being screened for HBV leads
to greater HBV knowledge, or vice versa). Lastly,
because of the non-random sampling of health work-
ers, our conclusions have limited generalizability to
other health workers in China, since all the participants
were relatively well-educated health workers whose
work specifically involved addressing health risks per-
taining to liver cancer. However, given the inadequate
HBV-related knowledge in this highly educated sample,
it is reasonable to assume that other health workers
have similar or poorer knowledge about HBV. Insofar
as health providers are the individuals most trusted to
provide health information and healthcare to the public
at large, better education of healthcare providers and
public health professionals isc r i t i c a lt od isseminating
HBV-related knowledge and preventive practices
throughout the population of China.
Implications for future initiatives
In spite of the limitations, our study also has several
strengths. To our knowledge, there have been no other
studies on HBV knowledge and practices performed on
such a broad representation of health professionals
from different provinces in China. Given the absence
of prior data, our findings present novel and valuable
information regarding the presence and nature of
knowledge deficits among local health workers, as well
as demonstrating a direct relationship between low
HBV-related knowledge and insufficient HBV preven-
tive practices.
Conclusions
Our study highlights the continuing need for greater
HBV knowledge in the rural reaches of China, as well as
creative health strategies that address the complexities
of translating HBV knowledge into effective prevention.
In addition, our results emphasize the importance of
establishing and enforcing patient privacy policies, as
well as improving general awareness about HBV trans-
mission, to abolish discrimination against chronically
infected individuals. With the combined effort of HBV
educated health workers, health providers, policy
makers, scientists, and government officials, the People’s
Republic of China can make even greater strides toward
eliminating HBV transmission and the burden of disease
due to this lethal yet preventable infection.
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